Chimeric Therapeutics Limited Stock Market Value
| CHMMF Stock | 0 0.00 0.00% |
| Symbol | Chimeric |
Chimeric Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Chimeric Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Chimeric Therapeutics.
| 10/24/2025 |
| 01/22/2026 |
If you would invest 0.00 in Chimeric Therapeutics on October 24, 2025 and sell it all today you would earn a total of 0.00 from holding Chimeric Therapeutics Limited or generate 0.0% return on investment in Chimeric Therapeutics over 90 days. Chimeric Therapeutics is related to or competes with HG Holdings, CCCB Bancorp, CNB Financial, Eventiko, and Empire Bancshares. More
Chimeric Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Chimeric Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Chimeric Therapeutics Limited upside and downside potential and time the market with a certain degree of confidence.
Chimeric Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chimeric Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Chimeric Therapeutics' standard deviation. In reality, there are many statistical measures that can use Chimeric Therapeutics historical prices to predict the future Chimeric Therapeutics' volatility.Chimeric Therapeutics Backtested Returns
We have found three technical indicators for Chimeric Therapeutics Limited, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Chimeric Therapeutics are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Chimeric Therapeutics Limited has no correlation between past and present. Overlapping area represents the amount of predictability between Chimeric Therapeutics time series from 24th of October 2025 to 8th of December 2025 and 8th of December 2025 to 22nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Chimeric Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Chimeric Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
Other Information on Investing in Chimeric Pink Sheet
Chimeric Therapeutics financial ratios help investors to determine whether Chimeric Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chimeric with respect to the benefits of owning Chimeric Therapeutics security.